SINGLE CENTER EXPERIENCE OF LONG TERM VEDOLIZUMAB EFFICACY IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Singh, Namita
Dubinsky, Marla
Singh, Avantika
Check, Morgan
Rabizadeh, Shervin
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)33258-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1759
引用
收藏
页码：S959 / S960
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Vedolizumab in Elderly Patients with Inflammatory Bowel Disease
    Navaneethan, Udayakumar
    Kommaraju, Kiran Kumar
    Edminster, Timothy
    Zhu, Xiang
    Wilson, Kenneth
    Glover, Sarah C.
    GASTROENTEROLOGY, 2016, 150 (04) : S812 - S812
  • [22] Vedolizumab Immunogenicity With Long-Term or Interrupted Treatment of Patients With Inflammatory Bowel Disease
    Wyant, Timothy
    Yang, Lili
    Lirio, Richard A.
    Rosario, Maria
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (09): : 1174 - 1181
  • [23] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison Borrman
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (05) : S1210 - S1211
  • [24] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    GASTROENTEROLOGY, 2024, 166 (03) : S101 - S102
  • [25] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hsu, Diane
    Lee, Justin
    Kotzen, Alison
    Bensen, Rachel
    Goyal, Alka
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S73 - S74
  • [26] REAL-WORLD SAFETY AND EFFICACY OF USTEKINUMAB AND VEDOLIZUMAB IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Anjur, Kavya
    Neiman, Nicole
    Kotzen, Alison
    Pond, Stephen
    Goyal, Alka
    GASTROENTEROLOGY, 2022, 162 (07) : S826 - S826
  • [27] Long-Term Use of Purine Analogues in Inflammatory Bowel Disease: A Single Referral Center Experience
    Issa, Mazen
    Zadvomova, Yelena
    Stein, Daniel J.
    Venu, Nanda
    Perera, Lilani P.
    Binion, David G.
    Naik, Amar S.
    GASTROENTEROLOGY, 2011, 140 (05) : S789 - S789
  • [28] Real-World Study on Vedolizumab Serum Concentration, Efficacy, and Safety after the Transition from Intravenous to Subcutaneous Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Experience
    Fric, Vlasta Orsic
    Borzan, Vladimir
    Sahinovic, Ines
    Borzan, Andrej
    Kurbel, Sven
    PHARMACEUTICALS, 2023, 16 (02)
  • [29] Long-Term Efficacy and Safety of Golimumab for Ulcerative Colitis in a Pediatric Inflammatory Bowel Disease Center in Japan
    Tokita, Kazuhide
    Shimizu, Hirotaka
    Takeuchi, Ichiro
    Shimizu, Toshiaki
    Arai, Katsuhiro
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2022, 25 (06) : 461 - 472
  • [30] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
    Huettemann, Eva
    Muzalyova, Anna
    Groehl, Katharina
    Nagl, Sandra
    Fleischmann, Carola
    Ebigbo, Alanna
    Classen, Johanna
    Wanzl, Julia
    Prinz, Friederike
    Mayr, Patrick
    Schnoy, Elisabeth
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
12345